Your medical cannabis journey simplified: find partnered dispensaries, explore pricing options, earn rewards, and get answers to FAQs, all in one spot.
December 7, 2022 01:00 pm ETEstimated Read Time: 4 Minutes
This fall, when President Biden announced his plan to reform U.S. cannabis policy federally, it included a call to review how cannabis is scheduled under the Controlled Substances Act (CSA). The CSA, which is regulated by the Drug Enforcement Administration (DEA), places all regulated substances into one of five schedules. The scheduling placement is based on the following:
The substance’s actual or relative potential for abuse
Scientific evidence of its pharmacological effect, if known
The state of current scientific knowledge regarding the drug or other substance
Its history and current pattern of abuse
The scope, duration, and significance of abuse
What, if any, risk there is to public health
Its psychic or physiological dependence liability
Whether the substance is an immediate precursor of a substance already controlled under this subchapter
Cannabis is difficult to place in one category of drugs because it has a wide range of effects, including the ability to depress, excite, and temporarily impair the central nervous system. Its medical value also has the risk of abuse. When seeking to find a drug or product’s medical value, a drug must have large-scale clinical trials to back it up—similar to what the Food and Drug Administration (FDA) would expect from any other drug entering the market. In the CSA, it is not clearly defined which federal agencies are responsible for classifying drugs.
Is the Fight to Reschedule Cannabis Worth It?
The laws and regulations surrounding cannabis are confusing. If it is federally illegal, how do states have the right to allow it? Would moving marijuana from the Schedule I category to a different bracket make it more likely to become legal in the United States? If the federal government is going to continue to allow states to make individual decisions about marijuana, regardless if it is categorized as Schedule I, is the fight to have it reclassified worth it?
Essentially, the schedule class given by the CSA does not interfere with the authority to keep marijuana enterprises open. Schedule I substances cannot be purchased legally in the United States. Schedule II drugs, such as morphine and fentanyl, are still considered to be dangerous drugs but are allowed to be prescribed for medical conditions.
See If You Qualify For Medical Marijuana -Select Your State!
If cannabis is moved to Schedule II, the concern is that the administrative change will make marijuana pharmaceuticals legal. This would require all products to be removed from the market until FDA approval is granted. FDA approval and clinical drug testing is not a small bump in the road—the approval often takes years and extremely large amounts of money.
What Drugs Have Been Rescheduled?
Several drugs have been rescheduled or reclassified. This is most commonly seen with medications that were once required to be given with a prescription but reclassified to over-the-counter. In 2014, the DEA reclassified the drug hydrocodone, moving it from Schedule III to Schedule II. But on the whole, reclassifying or unscheduling a substance is rather rare, and this has led to many controversies surrounding the CSA.
Research on the effect of reclassifying drugs shows that when a drug is reclassified to a more restrictive schedule, the use of the drug goes down. That is expected. The more barriers to the drug, the fewer users there will be. While this may seem like the intended outcome, it was also projected that negative outcomes can arise if the drug has too many barriers for patients to access. This is because patients in need of the substance who are unable to afford to see a prescribing doctor or have insurance to pay for prescription medication will be unable to obtain it.
Federal cannabis reform is tricky business. Though there seem to be more questions than answers at this point, the last decade has demonstrated how rapidly this industry can evolve. Most Americans agree that cannabis policy needs to change, but the path to reform is far from straightforward.
This article was originally written by Natasha Winkler and published on 2/17/20. Updated on 12/7/22.
Anna Schwartz completed her master's degree in public health with a focus on harm reduction. She is passionate about cannabis education and eliminating misinformation through data-driven research. Anna loves spending her free time in the great outdoors!
Getting comfortable with the most common weed weights and measurements can really come in handy when shopping for cannabis products. Gram, eighth, quarter, ounce—there are plenty of ways to measure cannabis, and just as many slang terms to go with them. Ultimately, these cannabis measurements can make shopping for marijuana by weight feel confusing fast….
Sometimes, your urine has a strange, weed-like, or other abnormal smell, and you might not be sure what’s causing it. This common experience often leads to online searches driven by curiosity or concern about potential health issues. This article explores some of the most common reasons behind a cannabis-like urine odor and other types of…
According to data recently released by Human Rights Watch, between 2002 and 2020, just over 127,000 people were deported for cannabis-related offenses. This number accounts for 35% of all deportations where drug-related charges were the most serious offense. Notably, this time includes several years when cannabis was illegal on both the state and federal levels….
One of the best things about cannabis is that it offers several benefits. However, most people use it strictly for fun – recreational purposes. But what if you could make another enjoyable activity even more pleasurable with cannabis? Well, according to multiple anecdotal and scientific reports, cannabis might help men put the ram in their…
Cannabis use for human athletes is increasingly popular because of its numerous therapeutic benefits. It’s a well-known and documented remedy used for centuries in both human and equine patients alike. However, it’s a newly revived trend for horse and rider athletes in the modern equestrian community. As the stigma and legalization of cannabis continue to…
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.